Sort
10,829 grants matching “car t”
Synthetic Mechano-Transduction For Improved Cell Therapies In Immuno-Oncology
$195,766Julien Berro · Yale University · R21 · FY2025 · CA
Adoptive Cellular Therapy of T Cell Lymphoma
$195,766Samuel G Katz · Yale University · R21 · FY2021 · CA
Cell and Genome Engineering Core
$195,763Mark J Osborn · University Of Minnesota · P01 · FY2025 · CA
Middle Ear Epithelial Response to Cytokine Stimulation
$195,753Medical College Of Wisconsin · K08 · FY2002 · DC
Modeling Risk for Hypogammaglobulinemia, Infections, and Mortality with Chimeric Antigen Receptor (CAR) T-cell Therapy
$195,750Sara Barmettler · Massachusetts General Hospital · K23 · FY2021 · AI
COHERENT ANTI-STOKES RAMAN SCATTERING (CARS) SYSTEM FOR TEMPERATURE AND SPECIES CONCENTRATION MEASUREMENTS
$195,650University Of Texas At Arlington · · FY2021 · Department of the Navy
Neurocognitive basis of attention and eye movement guidance in the real world scenes
$195,625Avniel S Ghuman · University Of Pittsburgh At Pittsburgh · R21 · FY2020 · EY
Novel hematopoietic humanized mouse model to study CAR-T therapy-associated cytokine release syndrome
$195,610Yong Fan · Allegheny-Singer Research Institute · R21 · FY2024 · OD
Trial to Examine Text Message-based mHealth in Emergency department patients with Diabetes with Family And friends Network Supporters (TExT-MED+FANS)
$195,534Elizabeth Rhea Erwin Burner · University Of Southern California · K23 · FY2019 · DK
Middle Ear Epithelial Response to Cytokine Stimulation
$195,510Medical College Of Wisconsin · K08 · FY2001 · DC
OR2H1 is an effective target for CAR T cells in human epithelial tumors
$195,472Jose R Conejo-Garcia · Duke University · R21 · FY2023 · CA
OTHER FUNCTIONS SBIR TOPIC 308 PHASE I: "MOBILE SOLUTION FOR OBJECTIVE DIETARY I
$195,179Praduman Jain · Vignet, Inc. · N43 · FY2012 · CA
ERI: Rethinking Traffic Flow in the Era of Electric Vehicles with Driver Assistance and Automation
$195,079Xingan D Kan · Florida Atlantic University · · FY2023 · ENG
Mobile Health and Treat (mHAT) for Malaria Elimination
$195,006David W Wright · Vanderbilt University · R21 · FY2017 · TW
Development of Long Lasting Stable Fentanyl Antagonist to Reverse Opioid Overdose
$195,000Jessica Priya Anand · University Of Michigan At Ann Arbor · R21 · FY2021 · DA
BIOPHYSICAL TUNING OF CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALING FOR SAFE AND EFFECTIVE T CELL IMMUNOTHERAPY
$195,000Kaushik Choudhuri · University Of Michigan At Ann Arbor · R21 · FY2021 · AI
Dual CMV and HIV CARs for Cure of HIV
$195,000Otto O Yang · University Of California Los Angeles · R21 · FY2020 · AI
Immunoengineering cellobiose as a fuel source for T cells
$195,000Manish J Butte · University Of California Los Angeles · R21 · FY2022 · AI
Technology-Enhanced Family-Focused Treatment for Adolescents at High Risk for Mood Disorders
$195,000David Jay Miklowitz · University Of California Los Angeles · R34 · FY2018 · MH
Genetically Modified Natural Killer Cells for Cancer Immunotherapy
$194,940Branden S Moriarity · University Of Minnesota · R21 · FY2019 · CA
Mobile Health Intervention to Improve Perinatal Continuum of Care in Guatemala
$194,889Gari David Clifford · Emory University · R21 · FY2015 · HD
Interactive Cognitive Behavioral Therapy for Insomnia
$194,868Daniel J Greenberg · Media Rez, Llc · R43 · FY2018 · CA
CRII: CPS: Provably-safe Interventions for Human-Cyber-Physical Systems (HCPS)
$194,802Sam Burden · University Of Washington · · FY2016 · CSE
Mobile phone surveys for noncommunicable disease risk factors in Uganda
$194,750Adnan A Hyder · Johns Hopkins University · R21 · FY2016 · TW
Mobile Telecare for Underserved African-American Elders with Heart Failure
$194,740Hongtu Chen · Environment And Health Group, Inc. · R43 · FY2014 · MD